COM:CITIUSPHARMA
Citius Pharmaceuticals, Inc.
- Stock
Last Close
0.17
22/11 21:00
Market Cap
25.79M
Beta: -
Volume Today
15.99M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 58.82K - | 332.66K 465.54% | 734.15K 120.69% | 755.79K 2.95% | 1.09M 43.95% | 2.14M 97.02% | 2.28M 6.60% | 1.57M 31.43% | 1.22M 22.05% | 2.05M 67.56% | |
average receivables | 409.17K - | 409.17K 0% | |||||||||
book value per share | -0.30 - | 4.63 1,646.13% | 4.00 13.49% | 2.60 35.14% | 1.21 53.43% | 0.86 28.90% | 1.22 41.58% | 0.70 42.17% | 0.60 14.71% | ||
capex per share | -0.00 - | -0.00 - | -0.37 787,891.81% | ||||||||
capex to depreciation | -0.01 - | -242.66 2,019,163.36% | |||||||||
capex to operating cash flow | 0.00 - | 0.00 - | 1.65 1,525,362.90% | ||||||||
capex to revenue | |||||||||||
cash per share | 0.32 - | 0.08 74.50% | 0.58 619.38% | 0.86 46.43% | 0.39 54.25% | 0.35 9.61% | 0.65 82.33% | 0.29 55.75% | 0.18 38.70% | ||
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.39 - | 0.03 - | 0.01 76.89% | 0.01 21.37% | 0.01 7.12% | 0.03 417.60% | 0.01 80.55% | 0.01 0.95% | 0.00 21.93% | ||
debt to equity | -0.81 - | 0.04 - | 0.01 80.36% | 0.01 21.24% | 0.01 14.30% | 0.04 465.94% | 0.01 83.88% | 0.01 1.92% | 0.01 19.67% | ||
dividend yield | |||||||||||
earnings yield | -0.05 - | -0.24 351.80% | -0.60 147.99% | -0.70 16.42% | -1.02 45.82% | -0.43 57.46% | -0.10 75.83% | -0.19 81.43% | -0.31 65.14% | ||
enterprise value | -952.06K - | 53.44M 5,713.52% | 34.62M 35.23% | 14.25M 58.83% | 8.91M 37.48% | 7.55M 15.26% | 28.22M 273.74% | 151.24M 435.85% | 135.73M 10.26% | 77.55M 42.87% | |
enterprise value over ebitda | -16.56 - | -4.65 71.93% | -1.43 69.29% | -0.71 50.14% | -0.49 31.75% | -1.62 234.28% | -6.56 304.12% | -4.13 37.11% | -2.12 48.58% | ||
ev to operating cash flow | -22.40 - | -5.87 73.81% | -1.79 69.52% | -0.79 55.97% | -0.61 22.88% | -1.67 174.56% | -6.24 274.11% | -4.79 23.26% | -2.67 44.24% | ||
ev to sales | |||||||||||
free cash flow per share | -1.12 - | -1.63 44.89% | -1.45 10.70% | -1.05 27.48% | -0.62 41.51% | -0.43 29.92% | -0.59 36.86% | -0.19 67.19% | -0.19 1.07% | ||
free cash flow yield | -0.04 - | -0.17 290.98% | -0.46 167.69% | -0.63 36.90% | -0.81 28.96% | -0.42 48.95% | -0.29 29.88% | -0.16 44.95% | -0.28 74.91% | ||
graham net net | -0.33 - | -1.35 308.81% | 0.13 109.93% | 0.62 359.67% | 0.16 73.55% | 0.10 41.15% | 0.56 480.08% | 0.21 61.69% | 0.09 55.65% | ||
graham number | 3.03 - | 15.44 408.80% | 13.06 15.40% | 8.26 36.75% | 4.58 44.50% | 2.95 35.56% | 2.41 18.26% | 1.91 20.92% | 1.70 10.74% | ||
income quality | 0.82 - | 0.71 13.46% | 0.77 7.92% | 0.90 17.62% | 0.80 11.47% | 0.96 20.72% | 1.05 9.02% | 0.84 19.85% | 0.89 5.92% | ||
intangibles to total assets | 0.00 - | 0.01 110.03% | 0.96 13,026.96% | 0.86 10.10% | 0.68 21.37% | 0.72 7.12% | 0.66 9.30% | 0.48 26.50% | 0.60 24.94% | 0.66 10.03% | |
interest coverage | -430.66 - | -828.25 92.32% | -11.74 98.58% | -870.64 7,317.43% | -948.63 8.96% | -1.13K 19.12% | -2.17K 92.13% | -132.52 93.90% | |||
interest debt per share | 0.00 - | 0.19 5,226.31% | 0.19 0.79% | 0.02 90.58% | 0.01 46.60% | 0.03 271.71% | 0.01 77.16% | 0.01 20.23% | 0.00 50.02% | ||
inventory turnover | |||||||||||
invested capital | -0.81 - | 0.04 - | 0.01 80.36% | 0.01 21.24% | 0.01 14.30% | 0.04 465.94% | 0.01 83.88% | 0.01 1.92% | 0.01 19.67% | ||
market cap | 54.12M - | 34.24M 36.73% | 17.28M 49.52% | 17.92M 3.69% | 15.27M 14.78% | 40.73M 166.70% | 220.46M 441.24% | 176.76M 19.82% | 103.55M 41.42% | ||
net current asset value | -747.34K - | -640.61K 14.28% | -4.29M 569.85% | 955.19K 122.26% | 6.88M 619.78% | 3.33M 51.50% | 3.88M 16.34% | 63.17M 1,528.46% | 33.99M 46.19% | 22.19M 34.72% | |
net debt to ebitda | 0.21 - | -0.05 124.26% | 0.30 697.18% | 0.72 137.08% | 0.50 31.00% | 0.72 44.89% | 3.00 317.36% | 1.25 58.46% | 0.71 42.97% | ||
net income per share | -1.37 - | -2.29 67.43% | -1.89 17.27% | -1.17 38.33% | -0.77 33.86% | -0.45 41.60% | -0.21 52.81% | -0.23 8.15% | -0.22 6.60% | ||
operating cash flow per share | -1.12 - | -1.63 44.89% | -1.45 10.72% | -1.05 27.46% | -0.62 41.51% | -0.43 29.93% | -0.22 48.34% | -0.19 13.06% | -0.19 1.07% | ||
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -3.94 - | -8.61 118.37% | -3.03 64.83% | -1.25 58.86% | -1.95 56.33% | -1.18 39.60% | -0.31 73.32% | -0.74 136.86% | -0.93 25.56% | ||
revenue per share | |||||||||||
roe | 4.57 - | -0.49 110.83% | -0.47 4.37% | -0.45 4.92% | -0.64 42.04% | -0.52 17.86% | -0.17 66.67% | -0.33 87.00% | -0.36 9.51% | ||
roic | 5.09 - | -0.43 108.40% | -0.49 14.22% | -0.54 11.00% | -0.64 17.31% | -0.49 22.17% | -0.18 64.38% | -0.33 84.56% | -0.41 25.21% | ||
sales general and administrative to revenue | |||||||||||
shareholders equity per share | -0.30 - | 4.63 1,646.13% | 4.00 13.49% | 2.60 35.14% | 1.21 53.43% | 0.86 28.90% | 1.22 41.58% | 0.70 42.17% | 0.60 14.71% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | -747.34K - | -640.61K 14.28% | -4.22M 558.81% | 960.59K 122.76% | 6.88M 616.11% | 3.39M 50.69% | 4.92M 45.17% | 64.04M 1,200.52% | 34.68M 45.84% | 22.68M 34.59% | |
tangible book value per share | -0.30 - | -1.16 285.91% | 0.18 115.04% | 0.64 265.83% | 0.17 73.75% | 0.13 25.27% | 0.59 369.02% | 0.24 59.74% | 0.15 36.84% | ||
working capital | -747.34K - | -640.61K 14.28% | -4.29M 569.85% | 955.19K 122.26% | 6.88M 619.78% | 3.33M 51.50% | 9.88M 196.47% | 68.83M 596.34% | 40.03M 41.84% | 28.59M 28.58% |
All numbers in (except ratios and percentages)